These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 15251373

  • 1. Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine.
    Dikow R, Degenhard M, Kraus T, Sauer P, Schemmer P, Uhl W, Büchler M, Zeier M.
    Transplant Proc; 2004 Jun; 36(5):1512-5. PubMed ID: 15251373
    [Abstract] [Full Text] [Related]

  • 2. Long-term glomerular filtration rate in liver allograft recipients according to the type of calcineurin inhibitors.
    Niel OR, Berthoux F, Albano L, Dahan P, Aoudia R, Gugenheim J, Cassuto E.
    Transplant Proc; 2009 Oct; 41(8):3329-32. PubMed ID: 19857743
    [Abstract] [Full Text] [Related]

  • 3. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy.
    Taler SJ, Textor SC, Canzanello VJ, Wilson DJ, Wiesner RH, Krom RA.
    Am J Hypertens; 1995 Jun; 8(6):598-605. PubMed ID: 7544983
    [Abstract] [Full Text] [Related]

  • 4. Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients.
    Hohage H, Brückner D, Arlt M, Buchholz B, Zidek W, Spieker C.
    Clin Nephrol; 1996 May; 45(5):342-4. PubMed ID: 8738668
    [Abstract] [Full Text] [Related]

  • 5. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA, Gimson AE, Gibbs P, Alexander GJ.
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [Abstract] [Full Text] [Related]

  • 6. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R, Cantarell C, Vargas V, Capdevila L, Lázaro JL, Hidalgo E, Murio E, Margarit C.
    Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
    [Abstract] [Full Text] [Related]

  • 7. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD, MacLeod R, Rigby E, Clark AG.
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [Abstract] [Full Text] [Related]

  • 8. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial.
    Meier M, Nitschke M, Weidtmann B, Jabs WJ, Wong W, Suefke S, Steinhoff J, Fricke L.
    Transplantation; 2006 Apr 15; 81(7):1035-40. PubMed ID: 16612281
    [Abstract] [Full Text] [Related]

  • 9. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec 15; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 10. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
    Bahra M, Neumann UP, Jacob D, Langrehr JM, Neuhaus P.
    Transplant Proc; 2005 May 15; 37(4):1700-2. PubMed ID: 15919436
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.
    Cholongitas E, Shusang V, Germani G, Tsochatzis E, Raimondo ML, Marelli L, Senzolo M, Davidson BR, Patch D, Rolles K, Burroughs AK.
    Clin Transplant; 2011 May 15; 25(4):614-24. PubMed ID: 20718824
    [Abstract] [Full Text] [Related]

  • 12. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 15; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 13. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Jacob DA, Neumann UP, Bahra M, Langrehr JM, Neuhaus P.
    Transplant Proc; 2005 May 15; 37(4):1691-2. PubMed ID: 15919432
    [Abstract] [Full Text] [Related]

  • 14. A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy.
    Kooman JP, Christiaans MH, Boots JM, van Der Sande FM, Leunissen KM, van Hooff JP.
    Am J Kidney Dis; 2001 Jun 15; 37(6):1170-6. PubMed ID: 11382685
    [Abstract] [Full Text] [Related]

  • 15. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M.
    Transplant Proc; 2005 Nov 15; 37(9):3738-42. PubMed ID: 16386523
    [Abstract] [Full Text] [Related]

  • 16. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients.
    Sánchez-Pérez B, Aranda Narváez JM, Santoyo Santoyo J, Fernández-Aguilar JL, Suárez Muñoz MA, González-Sánchez AJ, Pérez Daga JA, Ramírez Plaza CP, Carrasco Campos J, Jiménez Mazure C, Becerra Ortíz R.
    Transplant Proc; 2008 Nov 15; 40(9):2994-6. PubMed ID: 19010171
    [Abstract] [Full Text] [Related]

  • 17. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 18. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug 15; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 19. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
    Ott R, Bussenius-Kammerer M, Reck T, Koch CA, Kissler H, Hohenberger W, Müller V.
    Transpl Int; 2004 Jan 15; 17(1):39-43. PubMed ID: 14504723
    [Abstract] [Full Text] [Related]

  • 20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 15; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.